Chinese researcher in ‘economic warfare’ case loses appeal
GlaxoSmithKline also has a presence in Switzerland, including in Nyon, canton Vaud.
Keystone / Laurent Gillieron
A Swiss-based Chinese scientist, accused by the US of helping to steal trade secrets, must remain in Swiss custody due to flight risk, says the Federal Criminal Court.
In its decision published on MondayExternal link, the court rejected the appeal by Gongda Xue and said the hefty prison sentence he faces if extradited to the US – up to 20 years – means that releasing him from custody would be premature.
Xue was arrested by Swiss authorities in May, almost a year after the US embassy in Bern demanded that he be extradited on charges of economic espionage.
The researcher, who has lived in Switzerland for 18 years, is the brother of Yu Xue, a Chinese-American scientist who last August pleaded guilty at a US District Court in Pennsylvania to stealing secrets from UK-owned GlaxoSmithKline (GSK).
The US court claims that Gongda Xue received the stolen information from his sister and performed tests at the Basel-based Friedrich Miescher Institute for Biomedical Research (where he was employed until 2014) before sending the results to China.
‘Economic warfare’
The stolen information and tests allegedly involved the search for a cure for cancer, and more specifically, antibodies that bind to tumour cells and kill them.
US prosecutors estimate that the value of the stolen secrets amount to some $550 million (CHF545 million) and have characterised the case as an instance of “economic warfare”.
The Friedrich Miescher Institute confirmed to the Reuters news agency that it had employed Gongda Xue as a post-doctoral researcher but said it was not accusing him of any wrongdoing. The scientist’s lawyer declined to comment.
Swiss authorities continue to consider the extradition request by the US.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Switzerland is Europe’s most innovative country, EU study finds
This content was published on
In the European Commission's annual ranking, the Swiss score dropped slightly in 2025, but not enough to cost it top spot.
Women’s Euro 2025 has been largely peaceful so far
This content was published on
After two weeks of football fever in various Swiss host cities, no major incidents have been reported so far, police say.
Planned solar park at Bern airport scaled back after talks
This content was published on
The ground-mounted plant at Belpmoos Airport will be smaller than originally planned, the parties involved said on Tuesday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
High pharma margins squeeze health systems
This content was published on
Curing cancer for the masses could be challenging if healthcare systems are crippled by rapidly rising cancer drug prices.
This content was published on
The Swiss Federal Council has reported an increase in foreign espionage, particularly aided by technology and by spies posing as diplomats.
Chinese firms stole sensitive data from Swiss-based competitor
This content was published on
The news comes days after the Swiss Federal Intelligence Service had highlighted the ongoing threat of Chinese espionage in its annual report on the risks facing Switzerland. The SonntagsZeitungExternal link reports that the victim of this case was a Swiss subsidiary of the Dutch company BesiExternal link, which manufactures machines that make computer chips. The perpetrators…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.